{"id":"W1488432447","doi":"10.1186/1479-5876-13-s1-o6","title":"Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma","year":2015,"lang":"en","type":"article","venue":"Journal of Translational Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"ca_institutions":"Royal Victoria Hospital; Royal Victoria Regional Health Centre; BC Cancer Agency","funders":"","keywords":"Dacarbazine; Nivolumab; Melanoma; Medicine; Oncology; Overall survival; Internal medicine; Metastatic melanoma; Cancer research; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007943814,0.0001901609,0.0005488871,0.0001918013,0.0001417024,0.0002984201,0.000127517,0.0002491852,0.000952876],"category_scores_gemma":[0.001146593,0.00008735943,0.0006361294,0.0001978079,0.0001305464,0.0002872087,0.0001867792,0.00063948,0.0001086088],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004296025,"about_ca_system_score_gemma":0.0002498082,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008018631,"about_ca_topic_score_gemma":0.002997343,"domain_scores_codex":[0.9997062,0.0001438739,0.00001908682,0.00004073358,0.00003321117,0.0000568028],"domain_scores_gemma":[0.9995435,0.0001858793,0.00008528862,0.00002965971,0.00002527477,0.0001303655],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2707186,0.00304688,0.2317503,0.0007125986,0.003627315,0.0006628048,0.0004843898,0.006220474,0.01702718,0.0004319632,0.003741294,0.4615762],"study_design_scores_gemma":[0.02257415,0.1503352,0.796869,0.0002645939,0.002630347,0.001415279,0.000226161,0.007388791,0.003745122,0.001283171,0.01319882,0.00006938128],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9923136,0.005973229,0.0001046691,0.0003188199,0.00008810395,0.00001748981,0.00008415673,0.00001196332,0.001088074],"genre_scores_gemma":[0.9983432,0.0009309673,0.0000850809,0.0001515754,0.0000812396,0.000008594292,0.00009079776,0.000002033906,0.0003064866],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.000952876,"threshold_uncertainty_score":0.004201114,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01510315382828697,"score_gpt":0.2616498349889505,"score_spread":0.2465466811606635,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}